. . . . . . . "[Our analysis also identified PI3-kinase mutations as markers of poor prognosis in IDH-mutated?+?ATRX/TP53 mutated diffuse gliomas, median survival 3.7 v. 6.3�years (P?=?0.02, Hazard rate (HR) 2.93, 95�% confidence interval (CI) 1.16 - 7.38).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:16:52+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .